Isoquinolinesulfonyl derivative as RHO kinase inhibitor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9856264
SERIAL NO

15306965

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention discloses a class of isoquinolinesulfonyl derivatives as RHO kinase inhibitors, and pharmaceutical compositions thereof, and relates to pharmaceutically acceptable uses thereof. Specifically, the present invention relates to a compound as represented by formula (I), or a pharmaceutically acceptable salt thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LIMITEDBUILDING NO 7 COURTYARD NO 2 NORTH THIRD RING MIDDLE ROAD CHAOYANG DISTRICT BEIJING 100018

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Shuhui Shanghai, CN 339 290
Chen, Zhaoguo Shanghai, CN 16 11
Wu, Lingyun Shanghai, CN 45 68
Yao, Yuanshan Shanghai, CN 12 12

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 2, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 2, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00